Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Feb 3, 2016

29745_dirs_2016-02-03_33266b7d-26b2-4cb7-a4b6-c604b25e4cbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-02-01

Reporting Person: Fry Stephen F (SVP, HR & Diversity)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-01 Common Stock M 7252 Acquired 81467 Direct
2016-02-01 Common Stock F 3410 $79.10 Disposed 78057 Direct
2016-02-01 Common Stock S 2412 $78.39 Disposed 75645 Direct
2016-02-03 Common Stock S 725 $76.46 Disposed 74920 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-01 Restricted Stock Unit $ M 7252 Disposed 2016-02-01 Common Stock (7252.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 159 Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $78.19 to $78.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.